History | Dapagliflozin in triple therapy for treating type 2 diabetes | Guidance | NICE

History

Documents created during the development process.

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 290 KB)

Published:

07 October 2016
Committee papers (PDF 17.01 MB)

Published:

07 October 2016
Accessible version Equality Assessment Form (PDF 161 KB)

Published:

07 October 2016
Committee papers Clinical Effectiveness presentation slides (PDF 181 KB)

Published:

07 October 2016
Committee papers Cost Effectiveness presentation slides (PDF 306 KB)

Published:

07 October 2016

Invitation to participate

Equality impact assessment (Scoping) (PDF 119 KB)

Published:

16 March 2016
Final scope (PDF 105 KB)

Published:

07 October 2016
Final matrix (PDF 96 KB)

Published:

07 October 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 180 KB)

Published:

07 October 2016

Draft scope documents

Draft scope (post-referral) (PDF 104 KB)

Published:

29 January 2016
Provisional matrix (post-referral) (PDF 88 KB)

Published:

29 January 2016